ID: ALA2070378

Max Phase: Preclinical

Molecular Formula: C22H30N2O17P2S

Molecular Weight: 688.49

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=Cc1ccc(-c2cn([C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)CC[C@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H](O)[C@H]3O)c(=O)[nH]c2=O)s1

Standard InChI:  InChI=1S/C22H30N2O17P2S/c25-6-9-1-2-14(44-9)10-5-24(22(33)23-20(10)32)21-19(31)17(29)13(40-21)8-38-43(36,37)41-42(34,35)4-3-11-15(27)18(30)16(28)12(7-26)39-11/h1-2,5-6,11-13,15-19,21,26-31H,3-4,7-8H2,(H,34,35)(H,36,37)(H,23,32,33)/t11-,12-,13-,15+,16+,17-,18-,19-,21-/m1/s1

Standard InChI Key:  ZQWYKTYIVDEIFG-QTTXJACTSA-N

Associated Targets(non-human)

Beta-1,4-galactosyltransferase 1 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

N-acetyllactosaminide alpha-1,3-galactosyltransferase 17 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 688.49Molecular Weight (Monoisotopic): 688.0740AlogP: -2.75#Rotatable Bonds: 12
Polar Surface Area: 304.83Molecular Species: ACIDHBA: 17HBD: 9
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 1.96CX Basic pKa: CX LogP: -3.70CX LogD: -8.31
Aromatic Rings: 2Heavy Atoms: 44QED Weighted: 0.08Np Likeness Score: 0.79

References

1. Descroix K, Pesnot T, Yoshimura Y, Gehrke SS, Wakarchuk W, Palcic MM, Wagner GK..  (2012)  Inhibition of galactosyltransferases by a novel class of donor analogues.,  55  (5): [PMID:22356319] [10.1021/jm201154p]

Source